| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Strassburger Philip C. serves as a General Counsel at OCUL. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $785K at current prices.
Historically, Strassburger Philip C.'s trades have earned a below-average insider score of 24/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -45.6%.
The biggest single holding is OCUL (~$785K) as General Counsel. The recent filings there lean toward selling, a net 19,041 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | OCUL Ocular Therapeutix, Inc | General Counsel | Sell | 6,029 | $4.86 | $29,300.94 | -3.6% | +17.2% | +58.0% | |
| Jan 31, 2024 | OCUL Ocular Therapeutix, Inc | General Counsel | Sell | 6,831 | $4.95 | $33,813.45 | -5.9% | -2.5% | +60.1% | |
| Feb 6, 2023 | OCUL Ocular Therapeutix, Inc | General Counsel | Sell | 6,181 | $4.24 | $26,207.44 | -5.4% | +50.6% | +18.6% |